Antonio Portarapillo
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Journal: Dermatology and therapy
Published: March 11, 2026
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: August 12, 2025
Biologics and small molecules for psoriasis: current and future progress.
Journal: Drugs in context
Published: August 07, 2025
Jarisch-Herxheimer-Like Reaction After Griseofulvin Oral Intake for Tinea Infection Treatment.
Journal: Pediatric dermatology
Published: December 12, 2024
Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up.
Journal: Cancers
Published: July 04, 2024
Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris.
Journal: Life (Basel, Switzerland)
Published: June 28, 2024
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond.
Journal: Expert opinion on pharmacotherapy
Published: June 25, 2024
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation.
Journal: Expert opinion on drug safety
Published: May 03, 2024
Therapeutic management of infantile digital fibromatosis.
Journal: Italian journal of dermatology and venereology
Published: May 02, 2024
Risk Factors for Psoriasis Flares: A Narrative Review.
Journal: Psoriasis (Auckland, N.Z.)
Published: March 02, 2024
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study.
Journal: Clinical and experimental dermatology
Published: February 02, 2024
Last Updated: 09/26/2026